Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 26 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2009Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancerZinonos, I.; Labrinidis, A.; Lee, M.; Liapis, V.; Hay, S.; Ponomarev, V.; Diamond, P.; Zannettino, A.; Findlay, D.; Evdokiou, A.
2005Synergistic induction of prostate cancer cell death by g-tocotrienol and lovastatin is mediated by direct geranylgeranyl pyrophosphate inhibition through a caspase-independent pathwayOdysseos, A.; Vraka, P.; Liapis, V.; Hay, S.; Evdokiou, A.
2001Chemotherapeutic drugs sensitise osteogenic sarcoma cells but not normal human bone cells to TRAIL-mediated apoptosisAtkins, G.; Evdokiou, A.; Bouralexis, S.; Chai, F.; Hay, S.; Clayer, M.; Findlay, D.
2002Calcitonin decreases the adherence and survival of HEK-293 cells by a caspase-independent mechanismFindlay, D.; Raggatt, L.; Bouralexis, S.; Hay, S.; Atkins, G.; Evdokiou, A.
2000Expression of osteoclast differentiation signals by stromal elements of giant cell tumorsAtkins, G.; Haynes, D.; Graves, S.; Evdokiou, A.; Hay, S.; Bouralexis, S.; Findlay, D.
2000Sustained activation of Erk1/2 MAPK and cell growth suppression by the insert-negative, but not the insert-positive isoform of the human calcitonin receptorRaggatt, L.; Evdokiou, A.; Findlay, D.
2000Involvement of p21Waf1/Cip1 and its cleavage by DEVD-caspase during apoptosis of colorectal cancer cells induced by butyrateChai, F.; Evdokiou, A.; Young, G.; Zalewski, P.
2003Induction of cell death of human osteogenic sarcoma cells by zoledronic acid resembles anoikisEvdokiou, A.; Labrinidis, A.; Bouralexis, S.; Hay, S.; Findlay, D.
2004Sensitivity of fresh isolates of soft tissue sarcoma, osteosarcoma and giant cell tumour cells to Apo2L/TRAIL and doxorubicinBouralexis, S.; Clayer, M.; Atkins, G.; Labrinidis, A.; Hay, S.; Graves, S.; Findlay, D.; Evdokiou, A.
2002Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to APO2L/TRIAL-induced apoptosisEvdokiou, A.; Bouralexis, S.; Atkins, G.; Chai, F.; Hay, S.; Clayer, M.; Findlay, D.